Inovio Pharmaceuticals Inc. (INO) is priced at $11.32 after the most recent trading session. At the very opening of the session, the stock price was $10.25 and reached a high price of $11.38, prior to closing the session it reached the value of $10.08. The stock touched a low price of $10.23.
Recently in News on September 8, 2020, INOVIO Adds Thermo Fisher Scientific To Global Manufacturing Consortium. INOVIO Plans to Have 100 Million Doses of COVID-19 Vaccine Candidate INO-4800 Manufactured in 2021. You can read further details here
Inovio Pharmaceuticals Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $33.79 on 06/26/20, with the lowest value was $2.95 for the same time period, recorded on 01/06/20.
Inovio Pharmaceuticals Inc. (INO) full year performance was 337.07%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Inovio Pharmaceuticals Inc. shares are logging -66.50% during the 52-week period from high price, and 491.12% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.91 and $33.79.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 16157641 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Inovio Pharmaceuticals Inc. (INO) recorded performance in the market was 243.03%, having the revenues showcasing -20.00% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.83B, as it employees total of 190 workers.
Specialists analysis on Inovio Pharmaceuticals Inc. (INO)
During the last month, 5 analysts gave the Inovio Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 3 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 16.47, with a change in the price was noted -0.39. In a similar fashion, Inovio Pharmaceuticals Inc. posted a movement of -3.33% for the period of last 100 days, recording 32,762,268 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for INO is recording 0.43 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.43.
Trends and Technical analysis: Inovio Pharmaceuticals Inc. (INO)
Raw Stochastic average of Inovio Pharmaceuticals Inc. in the period of last 50 days is set at 12.85%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 40.36%. In the last 20 days, the company’s Stochastic %K was 23.71% and its Stochastic %D was recorded 18.48%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 243.03%. Additionally, trading for the stock in the period of the last six months notably improved by 84.67%, alongside a boost of 337.07% for the period of the last 12 months. The shares increased approximately by 18.29% in the 7-day charts and went up by -21.33% in the period of the last 30 days. Common stock shares were lifted by -20.00% during last recorded quarter.